clinical data analytics
Scope
Date
~
-
Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Artificial intelligence
LIG Nex1 opens AI research lab jointly with Korea Robot Institute
LIG Nex1 Co. said on Wednesday that it held an "AI Co-Lab" opening ceremony at the Seoul office of the Korea Institute of Robot and Convergence (KIR...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio's diagnostic products start to be used in clinical tests in Vietnam
South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...
Jan 19, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Korea internet data center construction faces health issue
South Korea’s information technology industry hit a snag with building new internet data centers (IDCs) due to controversies over the potentia...
Jan 17, 2023 (Gmt+09:00)
-
Banking & Finance
Kookmin Bank launches foreign currency trading platform KB Star FX
South Korea's largest lender Kookmin Bank on Monday launched its new contactless platform for foreign exchange transactions dubbed KB Star FX.The on...
Jan 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Food & Beverage
Pulmuone builds data sharing cluster for factories
South Korea's major plant-based food company Pulmuone Co. Ltd. said on Monday that it has built a "digital cluster smart factory" that can share, in...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GCCL develops Korea's first automatic clinical trial data sharing system
Global Clinical Central Lab (GCCL), an affiliate of South Korean pharmaceutical firm Green Cross Corp., said on Monday it has jointly developed Kore...
Jan 10, 2023 (Gmt+09:00)
-
Korean startups
Korean startup Lemonbase attracts $5.6 mn Series A funding
Lemonbase, a South Korean developer and operator of performance management software as a service (Saas), raised 7 billion won ($5.6 million) in Seri...
Jan 09, 2023 (Gmt+09:00)
-
Leadership & Management
Kyobo Life chief says data can overcome uncertain future
Shin Chang-jae, chairman and CEO of South Korea's Kyobo Life Insurance, has urged the overcoming of the economic crisis based on leadership of VUCA,...
Jan 09, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Point2 Technology to supply network cable solutions to Amazon
Point2 Technology, which specializes in high-speed communications solutions, said on Wednesday that it has signed a network cable solution supply co...
Jan 06, 2023 (Gmt+09:00)
-
Korean Investors
Mirae Asset buys logistics center in India for $17 mn
Mirae Asset Global Managements Co. said on Friday that it has invested 21 billion won ($17 million) in a large logistics center in Mumbai to become ...
Jan 06, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
HD Hyundai to boost offshore wind power, future ships, CEO says
LAS VEGAS – HD Hyundai Co., the largest shipbuilding conglomerate in South Korea, is set to diversify its future growth engines, focusing on s...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
ESG
POSCO Gwangyang Works obtains green data center certificiation
POSCO Gwangyang Works, one of the two pillar steel mills of POSCO Holdings Inc. together with Pohang Works, obtained a Green Data Center Bronze Grad...
Dec 29, 2022 (Gmt+09:00)
-
Cloud computing
KFTC acts on Amazon's large share of S.Korea's cloud market
Amazon controls around 70% of South Korea's cloud market, followed by Microsoft in second and Google and Naver Corp. fighting for third place.The Ko...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
KT builds hyper-connected R&D network KOREN data site
KT Corp. said on Monday that it will start operation on Jan. 5 after completing the construction of KOREN data lake portal site, which provides vari...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Electronics
LG to develop smart home devices responsive to users’ sleep data
An air conditioner or a TV set equipped with a timer that automatically turns power on and off based on the user's preference has been around for ye...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
CJ OliveNetworks develops factory big data solution
South Korea's IT service management firm CJ OliveNetworks Co. Ltd. said on Wednesday that it has developed a real-time database (RTDB), a data manag...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Artificial intelligence
ESTsoft completes construction of studio dedicated to AI virtual humans
South Korea's application software developer ESTsoft Corp. said on Tuesday that it has built a dedicated studio in its headquarters in Seoul's Gangn...
Dec 14, 2022 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs